ticlopidine has been researched along with Infarct in 9 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with API (lacunar infarcts or branch atheromatous disease) admitted within 48 hours after onset were enrolled." | 6.82 | [Argatroban, Aspirin, and Clopidogrel Combination Therapy for Acute Penetrating Artery Infarction: A Pilot Study]. ( Kobayashi, Y; Mano, T; Matsuo, K; Nishi, R, 2016) |
| "Patients with API (lacunar infarcts or branch atheromatous disease) admitted within 48 hours after onset were enrolled." | 2.82 | [Argatroban, Aspirin, and Clopidogrel Combination Therapy for Acute Penetrating Artery Infarction: A Pilot Study]. ( Kobayashi, Y; Mano, T; Matsuo, K; Nishi, R, 2016) |
| "Moreover only 1 case of spinal cord infarction was attributed to paradoxical embolism through PFO, but in the anterior spinal artery territory." | 1.36 | Posterior spinal artery infarct due to patent foramen ovale: a case report. ( Federico, F; Fraddosio, A; Giorelli, M; Lucivero, V; Petruzzellis, M; Prontera, M; Tinelli, A, 2010) |
| "This is the first case of renal infarction that developed in the early hours of primary PCI, despite effective anticoagulant and antiplatelet treatment." | 1.36 | Acute myocardial infarction and renal infarction in a bodybuilder using anabolic steroids. ( Calık, AN; Demirci, D; Güvenç, TS; Ilhan, E, 2010) |
| "Isolated splenic infarction as a complication of the procedure is extreme rare." | 1.35 | Athero-embolic isolated splenic infarction following left cardiac catheterization. ( Hussein, A; Irani, F; Kasmani, R; Mohan, G, 2009) |
| "Ticlopidine was significantly effective only at 100 mg/kg p." | 1.28 | Effect of (+/-)-2-(dimethylamino)-1-[[o-(m-methoxyphenethyl)phenoxy] methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease. ( Hara, H; Kitajima, A; Shimada, H; Tamao, Y, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Downey, JM | 1 |
| Cohen, MV | 1 |
| Fernandez-Jimenez, R | 1 |
| Sanchez-Gonzalez, J | 1 |
| Ibanez, B | 1 |
| Vilahur, G | 1 |
| Gutiérrez, M | 1 |
| Casani, L | 1 |
| Varela, L | 1 |
| Capdevila, A | 1 |
| Pons-Lladó, G | 1 |
| Carreras, F | 1 |
| Carlsson, L | 1 |
| Hidalgo, A | 1 |
| Badimon, L | 1 |
| Nishi, R | 1 |
| Mano, T | 1 |
| Kobayashi, Y | 2 |
| Matsuo, K | 1 |
| Hussein, A | 1 |
| Kasmani, R | 1 |
| Irani, F | 1 |
| Mohan, G | 1 |
| Petruzzellis, M | 1 |
| Fraddosio, A | 1 |
| Giorelli, M | 1 |
| Prontera, M | 1 |
| Tinelli, A | 1 |
| Lucivero, V | 1 |
| Federico, F | 1 |
| Ilhan, E | 1 |
| Demirci, D | 1 |
| Güvenç, TS | 1 |
| Calık, AN | 1 |
| Hara, H | 1 |
| Shimada, H | 1 |
| Kitajima, A | 1 |
| Tamao, Y | 1 |
| Zoja, C | 1 |
| Perico, N | 1 |
| Bergamelli, A | 1 |
| Pasini, M | 1 |
| Morigi, M | 1 |
| Dadan, J | 1 |
| Belloni, A | 1 |
| Bertani, T | 1 |
| Remuzzi, G | 1 |
1 trial available for ticlopidine and Infarct
| Article | Year |
|---|---|
[Argatroban, Aspirin, and Clopidogrel Combination Therapy for Acute Penetrating Artery Infarction: A Pilot Study].
Topics: Acute Disease; Aged; Arginine; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Infa | 2016 |
8 other studies available for ticlopidine and Infarct
| Article | Year |
|---|---|
Letter by Downey and Cohen Regarding Article, "Protective Effects of Ticagrelor on Myocardial Injury After Infarction".
Topics: Humans; Infarction; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine | 2017 |
Letter by Fernandez-Jimenez et al Regarding Article, "Protective Effects of Ticagrelor on Myocardial Injury After Infarction".
Topics: Humans; Infarction; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine | 2017 |
Response by Vilahur et al to Letters Regarding Article, "Protective Effects of Ticagrelor on Myocardial Injury After Infarction".
Topics: Humans; Infarction; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine | 2017 |
Athero-embolic isolated splenic infarction following left cardiac catheterization.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aortic Aneurysm, Abdominal; Aspirin; Atherosclerosis | 2009 |
Posterior spinal artery infarct due to patent foramen ovale: a case report.
Topics: Disease-Free Survival; Female; Foramen Ovale, Patent; Humans; Infarction; Magnetic Resonance Imaging | 2010 |
Acute myocardial infarction and renal infarction in a bodybuilder using anabolic steroids.
Topics: Adult; Anabolic Agents; Angiography; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopid | 2010 |
Effect of (+/-)-2-(dimethylamino)-1-[[o-(m-methoxyphenethyl)phenoxy] methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease.
Topics: Animals; Arterial Occlusive Diseases; Carrageenan; Fibrinolytic Agents; Infarction; Lauric Acids; Ma | 1991 |
Ticlopidine prevents renal disease progression in rats with reduced renal mass.
Topics: Animals; Biphenyl Compounds; Bleeding Time; Blood Pressure; Hematocrit; Heptanoic Acids; Infarction; | 1990 |